Overview

Registers Champions are recognised for their exceptional dedication to the BSR biologics and biosimilars registers.

Through outstanding efforts in patient recruitment, follow-up, and data quality, they help shape the future of rheumatology care. Their commitment makes a real difference—ensuring the success of the registers and supporting better outcomes for people living with rheumatic conditions. Learn more about our recent Registers Champions below. 


Celebrating 25 Years of the Rheumatoid Arthritis Register

This year marks 25 years of the RA Register, an incredible milestone to recognise today, on Rheumatoid Arthritis Awareness Day.
Find out more

Register Champion: Anne-Marie

Introducing Anne-Marie, one of our fantastic Register Champions on the BSRBR-RA study. Based at Kettering General Hospital, Anne-Marie plays a vital role in identifying, recruiting, and supporting patients to take part in the register.
Find out more

Register Champion: Rachel Vincent

“But overall my top tip would be to be proud of working on the BSRBR-RA, it really is a privilege to be part of somethin
Find out more

Register Champion: Ellen Lacey

Ellen’s fantastic efforts in both recruiting participants and submitting scheduled follow-ups have earned her the title of ‘Register Champion’; this highlights her commitment and impact on this long-term study.
Find out more

Register Champion – Danielle Miller

Danielle is an experienced children’s research nurse who has worked on the UK JIA Biologics Register for a number of years at Nuffield Orthopaedic Centre (Oxford), with Dr Kathy Bailey as the Principal Investigator at this site.
Find out more

Register Champion: Great North Children's Hospital

There is a fantastic team effort to keep the UK JIA Biologics Register studies running successfully. We asked PI Dr Flora McErlane how she and her team works to keep on top of recruitment and follow up.
Find out more

We encourage all rheumatology teams to keep submitting high-quality data to the BSR Biologics Registers

Your contributions are vital to improving patient care and advancing research.

"“New treatment options such as JAK inhibitors are becoming available for children with JIA, and UK JIA Biologics Register data will be key to improving our understanding of their safety and efficacy in children. I feel proud to have contributed to these studies.”"

Dr Flora McErlane
,

"I have tried to make research an integral part of the service, and not something separate that happens and creates more work for everyone. I am very passionate that every child eligible for any study has the opportunity to take part in research, if they wish to."

Danielle Miller
,

"“I like to reassure families that their input in the study can be as minimal as they choose. This has been a big selling point to families with lots of medical appointments and potentially having different diagnoses to think about” "

Ellen Lacey, University Hospital Southampton
,